GBIO logo

Generation Bio Co (GBIO) Company Overview

Profile

Full Name:

Generation Bio Co.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 12, 2020

Indexes:

Not included

Website:

http://generationbio.com

Description:

Generation Bio Co is a biotechnology company focused on developing innovative gene therapies. They aim to treat genetic diseases by using their unique platform to deliver genes directly to patients' cells, offering potential long-term solutions for conditions that currently have limited treatment options.

Key Details

Price

$0.60

Market Cap

$39.85 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$5.90 M

Annual EPS

-$1.96(+16.60% YoY)

PE Ratio

-

Annual ROE

-52.14%

Annual Debt To Equity

0.00

Beta

2.95

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 8, 25 Needham
Buy
Oct 23, 24 Needham
Buy
Aug 8, 24 Wedbush
Outperform
Aug 8, 24 Needham
Buy
May 14, 24 Wedbush
Outperform
May 14, 24 Needham
Buy
Apr 10, 24 Needham
Buy
Mar 7, 24 Wedbush
Outperform
Mar 7, 24 Needham
Buy
Nov 10, 23 Wedbush
Outperform

Screeners with GBIO included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.60
GBIO price is $0.60

Price All-time High

$51.61
GBIO price is currently -98.84% below its historical high of $51.61

Price Analysts Target

$7.00
GBIO price is currently -91.48% lower than the consensus analysts' forecast

Price Today Change

-2.13%
GBIO price is down -2.13% today

Price YTD Change

-44.76%
GBIO price is down -44.76% since January 1st

Price 3-Year Change

-86.92%
GBIO price is down -86.92% over the past 3 years

Market cap

Market Cap

$39.85 M
GBIO market capitalization is $39.85 million

Market Cap 3-Year Change

-84.67%
GBIO market capitalization is down -84.67% over the past 3 years

Market Cap All-time High

$2.40 B
GBIO market capitalization is currently -98.34% below its historical high of $2.40 billion

Market Cap Sector Rank

33.01%
GBIO market capitalization is higher than 33.01% of companies in Healthcare sector

Technical

Beta

2.95
GBIO beta is 2.95

200-day SMA

$2.16
GBIO price is currently -72.34% below its 200-day simple moving average

14-day RSI

28.66
GBIO 14-day relative strength index is 28.66

30-day Relative Volume

0.94
GBIO 30-day relative volume is 0.94

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$5.90 M
GBIO annual revenue is $5.90 million

Annual Revenue Analysts Estimate

$18.14 M
GBIO annual revenue is currently -67.45% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-
GBIO annual revenue 1-year change is unknown

Annual Revenue Sector Rank

23.88%
GBIO annual revenue is higher than 23.88% of companies in Healthcare sector

Profit

Annual Gross Profit

-
GBIO annual gross profit value is unknown

Annual Gross Margin

-
GBIO annual gross profit margin value is unknown

Annual Operating Profit

-$138.56 M
GBIO annual operating income is -$138.56 million

Annual Operating Margin

-2346.93%
GBIO annual operating profit margin is -2346.93%

Annual Net Income

-$126.61 M
GBIO annual net profit is -$126.61 million

Annual Net Margin

-2144.51%
GBIO annual net profit margin is -2144.51%

EPS

Annual EPS

-$1.96
GBIO annual earnings per share is -$1.96

Annual EPS Analysts Estimate

-$1.87
GBIO annual earnings per share is currently +5.02% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+16.6%
GBIO annual earnings per share is up +16.6% year-on-year

Annual EPS Sector Rank

43.44%
GBIO annual earnings per share is higher than 43.44% of companies in Healthcare sector

ROA & ROE

Annual ROA

-33.72%
GBIO annual return on assets is -33.72%

Annual ROE

-52.14%
GBIO annual return on equity is -52.14%

EBIT & EBITDA

Annual EBIT

-$138.56 M
GBIO annual earnings before interest & taxes is -$138.56 million

Annual EBITDA

-$133.30 M
GBIO annual EBITDA is -$133.30 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
GBIO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
GBIO price to earnings ratio is unknown

PB Ratio

PB Ratio

0.38
GBIO price to book ratio is 0.38

PB Ratio Sector Rank

24.18%
GBIO price to book ratio is higher than 24.18% of companies in Healthcare sector

PS Ratio

PS Ratio

2.14
GBIO price to sales ratio is 2.14

PS Ratio Sector Rank

40.75%
GBIO price to sales ratio is higher than 40.75% of companies in Healthcare sector

Enterprise value

Enterprise Value

$111.97 M
GBIO enterprise value is $111.97 million

Enterprise Value Sector Rank

49.71%
GBIO enterprise value is higher than 49.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.21
GBIO EV/EBITDA is -1.21

EV/EBITDA Sector Rank

44.31%
GBIO EV/EBITDA is higher than 44.31% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

6.83
GBIO annual current ratio is 6.83

Annual Quick Ratio

-
GBIO annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
GBIO annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
GBIO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GBIO piotroski f-score value is unknown

Altman Z-Score

-2.45
GBIO altman z-score is -2.45

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$374.76 M
GBIO annual total assets is $374.76 million

Annual Non Current Assets

$102.14 M
GBIO annual long term assets is $102.14 million

Annual Current Assets

$272.62 M
GBIO annual total current assets is $272.62 million

Annual Cash & Cash Equivalents

$66.45 M
GBIO annual cash & cash equivalents is $66.45 million

Equity

Annual Book Value

$203.13 M
GBIO annual book value is $203.13 million

Annual Working Capital

$232.70 M
GBIO annual working capital is $232.70 million

Liabilities

Annual Total Liabilities

$171.63 M
GBIO annual total liabilities is $171.63 million

Annual Total Long Term Liabilities

$131.72 M
GBIO annual total long term liabilities is $131.72 million

Annual Current Liabilities

$39.91 M
GBIO annual total current liabilities is $39.91 million

Annual Accounts Payable

$2.35 M
GBIO annual accounts payable is $2.35 million

Debt

Annual Total Debt

$97.89 M
GBIO annual total debt is $97.89 million

Annual Total Debt 1-Year Change

+19.81%
GBIO annual total debt is up +19.81% year-on-year

Annual Long Term Debt

$89.77 M
GBIO annual long term debt is $89.77 million

Annual Short Term Debt

$8.12 M
GBIO annual short term debt is $8.12 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$144.47 M
GBIO annual total expenses is $144.47 million

Annual Operating Expenses

$144.47 M
GBIO annual total operating expenses is $144.47 million

Annual Cost Of Goods Sold

-
GBIO annual cost of goods sold value is unknown

Annual SGA

$50.85 M
GBIO annual SGA is $50.85 million

Annual D&A

$5.26 M
GBIO annual depreciation & amortization is $5.26 million

Annual Interest Expense

-
GBIO annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$52.74 M
GBIO annual cash flow from operations is -$52.74 million

Annual CFO 1-Year Change

+48.52%
GBIO annual cash flow from operations is up +48.52% year-on-year

Annual CFI

-$9.70 M
GBIO annual cash flow from investing activities is -$9.70 million

Annual CFI 1-Year Change

+94.96%
GBIO annual cash flow from investing activities is up +94.96% year-on-year

Annual CFF

$35.82 M
GBIO annual cash flow from financing activities is $35.82 million

Annual CFF 1-Year Change

+175.75%
GBIO annual cash flow from financing activities is up +175.75% year-on-year

Free CashFlow

Annual FCF

-$60.14 M
GBIO annual free cash flow is -$60.14 million

Annual FCF 1-Year Change

+45.94%
GBIO annual free cash flow is up +45.94% year-on-year

CAPEX

Annual CAPEX

$7.40 M
GBIO annual capital expenditures is $7.40 million

Annual CAPEX 1-Year Change

-15.95%
GBIO annual capital expenditures is down -15.95% year-on-year

Institutional Ownership

Similar stocks

SCYX logo
SCYNEXIS (SCYX)
VYNE logo
VYNE Therapeutics (VYNE)
CELU logo
Celularity (CELU)
BRNS logo
Barinthus Biotherapeutics (BRNS)
XLO logo
Xilio Therapeutics (XLO)
INKT logo
MiNK Therapeutics (INKT)
TPST logo
Tempest Therapeutics (TPST)
Pheton Holdings Ltd Class A (PTHL)
Spectral AI (MDAI)

FAQ

  • What is the ticker symbol for Generation Bio Co?
  • Does Generation Bio Co pay dividends?
  • What sector is Generation Bio Co in?
  • What industry is Generation Bio Co in?
  • What country is Generation Bio Co based in?
  • When did Generation Bio Co go public?
  • Is Generation Bio Co in the S&P 500?
  • Is Generation Bio Co in the NASDAQ 100?
  • Is Generation Bio Co in the Dow Jones?
  • When was Generation Bio Co's last earnings report?
  • When does Generation Bio Co report earnings?
  • Should I buy Generation Bio Co stock now?

What is the ticker symbol for Generation Bio Co?

The ticker symbol for Generation Bio Co is NASDAQ:GBIO

Does Generation Bio Co pay dividends?

No, Generation Bio Co does not pay dividends

What sector is Generation Bio Co in?

Generation Bio Co is in the Healthcare sector

What industry is Generation Bio Co in?

Generation Bio Co is in the Biotechnology industry

What country is Generation Bio Co based in?

Generation Bio Co is headquartered in United States

When did Generation Bio Co go public?

Generation Bio Co's initial public offering (IPO) was on June 12, 2020

Is Generation Bio Co in the S&P 500?

No, Generation Bio Co is not included in the S&P 500 index

Is Generation Bio Co in the NASDAQ 100?

No, Generation Bio Co is not included in the NASDAQ 100 index

Is Generation Bio Co in the Dow Jones?

No, Generation Bio Co is not included in the Dow Jones index

When was Generation Bio Co's last earnings report?

Generation Bio Co's most recent earnings report was on Nov 6, 2024

When does Generation Bio Co report earnings?

The next expected earnings date for Generation Bio Co is Mar 6, 2025

Should I buy Generation Bio Co stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions